Patients with relapsed/refractory diffuse large B cell lymphoma with extranodal (esp. central
nervous system) involvement treated with Low-Dose Decitabine plus anti-PD-1 regimen. 3 weeks
for a cycle, with a total of 2 years or until the disease progress esor unacceptable toxicity
occurs, or the patient decides to withdraw from the trial.